David Lawrence
2016
In 2016, David Lawrence earned a total compensation of $1.4M as Chief, Business Operations and Principal Accounting Officer at Acorda Therapeutics, a 11% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $174,046 |
| Option Awards | $368,411 |
| Salary | $366,054 |
| Stock Awards | $369,334 |
| Other | $7,950 |
| Total | $1,360,795 |
Lawrence received $369.3K in stock awards, accounting for 27% of the total pay in 2016.
Lawrence also received $75K in bonus, $174K in non-equity incentive plan, $368.4K in option awards, $366.1K in salary and $8K in other compensation.
Rankings
In 2016, David Lawrence's compensation ranked 6,736th out of 14,075 executives tracked by ExecPay. In other words, Lawrence earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,736 out of 14,075 | 52nd |
Division Manufacturing | 2,511 out of 5,489 | 54th |
Major group Chemicals And Allied Products | 819 out of 1,895 | 57th |
Industry group Drugs | 629 out of 1,538 | 59th |
Industry Biological Products, Except Diagnostic Substances | 115 out of 279 | 59th |
Source: SEC filing on April 21, 2017.
Lawrence's colleagues
We found five more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2016.
2016
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2016
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2016
Jane Wasman
Acorda Therapeutics
General Counsel
2016
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2016
Michael Rogers
Acorda Therapeutics